Online citations, reference lists, and bibliographies.
← Back to Search

Early Stages Of Mesothelioma, Screening And Biomarkers.

S. Klebe, D. Henderson
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The early diagnosis of mesothelioma is notoriously difficult, both from a clinical and pathological perspective. Patients often undergo several medical investigations without definitive diagnosis. The discovery of biomarkers that can be assessed in pleural effusions, histological samples, and serum may assist with the difficult early diagnosis of mesothelioma. In this chapter we focus on those markers that have been examined in the setting of either early diagnosis of mesothelioma in symptomatic individuals or that have been proposed as suitable for screening of asbestos-exposed individuals, with an emphasis on cytology and histology.
This paper references
10.1038/modpathol.3800534
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
H. Yaziji (2006)
10.1309/LX7NFRDXY1JQF9R1
Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions.
M. Wu (2007)
10.1016/S0720-048X(02)00302-9
Lung cancer screening with low-dose CT.
S. Diederich (2003)
10.1096/fj.04-1723fje
Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema
M. Papadopoulos (2004)
10.1111/j.1440-1827.2006.02024.x
Molecular tumor markers for asbestos‐related mesothelioma: Serum diagnostic markers
M. Maeda (2006)
10.1309/F1B64CL7H8VJKEAF
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.
R. Hassan (2005)
10.1007/BF01221194
GlutathioneS-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study
K. Segers (2005)
10.1136/gut.2006.109868
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
Chun-Ying Wu (2007)
10.1002/DC.20643
WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions
Weijian Zhu (2007)
10.1002/DC.2840030308
Value of immunocytochemistry in the study of malignant effusions
M. Mason (1987)
10.1007/978-3-7091-0651-8_102
Aquaporin-1 expression in human glial tumors suggests a potential novel therapeutic target for tumor-associated edema.
K. Oshio (2003)
10.1016/J.LUNGCAN.2005.03.020
Soluble mesothelin-related protein--a blood test for mesothelioma.
B. Robinson (2005)
10.1007/s00280-007-0500-1
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma
G. Gordon (2007)
10.1021/bi901762y
Rapid and reversible inhibition of aquaporin-4 by zinc.
Y. Yukutake (2009)
10.1016/j.autrev.2009.04.004
Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
P. Saikali (2009)
10.1007/s10157-008-0118-6
Aquaporin water channels in mammals
K. Ishibashi (2008)
10.1159/000063697
Renal Concentrating and Diluting Function in Deficiency of Specific Aquaporin Genes
A. Verkman (2002)
Expression of aquaporin-1 in human peritoneal mesothelial cells and its upregulation by glucose in vitro.
K. Lai (2001)
10.1016/j.bbrc.2009.03.042
Tumorigenic properties of alternative osteopontin isoforms in mesothelioma.
S. Ivanov (2009)
10.1016/S0140-6736(03)14794-0
Mesothelin-family proteins and diagnosis of mesothelioma
B. Robinson (2003)
10.1043/1543-2165-133.8.1317
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
A. Husain (2009)
10.1097/00029330-200712020-00024
Expression of aquaporin-1 in rat pleural mesothelial cells and its specific inhibition by RNA interference in vitro.
Wei Zhang (2007)
10.1159/000326249
Diagnostic Utility of GLUT-1 Expression in the Cytologic Evaluation of Serous Fluids
A. Afify (2005)
10.1016/S1556-0864(15)31535-5
Soluble Mesothelin Related Protein in Mesothelioma
J. Creaney (2006)
10.1053/j.semtcvs.2009.06.007
Current status of screening for malignant pleural mesothelioma.
H. Pass (2009)
10.1002/DC.20594
Immunocytochemical study of the expression of mesothelin in fine‐needle aspiration biopsy specimens of pancreatic adenocarcinoma
Amy C Baruch (2007)
10.1158/1078-0432.CCR-07-1613
Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma
K. Shiomi (2008)
10.1136/jcp.48.1.18
Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue.
E. Navratil (1995)
10.1016/j.tem.2005.11.009
Aquaporin-1: a novel promoter of tumor angiogenesis
C. Clapp (2006)
10.1097/00005792-199705000-00001
The aquaporin family of water channel proteins in clinical medicine.
M. Lee (1997)
10.1080/ann.34.3.192.200
Physiological importance of aquaporin water channels
A. Verkman (2002)
10.1097/00005382-200001000-00005
Screening for lung cancer.
C. Henschke (2000)
10.1097/MCP.0b013e32812144bb
Biomarkers for mesothelioma
A. Scherpereel (2007)
Lessons on renal physiology from transgenic mice lacking aquaporin water channels.
A. Verkman (1999)
10.1007/978-3-540-79885-9_19
Design, synthesis and assaying of potential aquaporin inhibitors.
Rose Haddoub (2009)
10.1111/j.1365-2559.2006.02442.x
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
J. King (2006)
10.1111/j.1349-7006.2007.00715.x
Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells
C. Sapede (2008)
10.1111/j.1365-2141.2006.06218.x
Osteopontin: a bridge between bone and blood
D. Haylock (2006)
10.1097/JTO.0b013e318180477b
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
J. Creaney (2008)
10.1146/ANNUREV.BIOCHEM.68.1.425
Cellular and molecular biology of the aquaporin water channels.
M. Borgnia (1999)
10.1093/AJCP/110.2.191
The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
W. E. Mangano (1998)
10.1046/j.1365-2559.1996.d01-562.x
Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME‐1 expression
A. Bateman (1997)
10.2353/AJPATH.2006.050596
Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth.
M. Hoque (2006)
10.1684/BDC.2008.0576
Nouveaux marqueurs diagnostiques du mésothéliome pleural malin
B. Grigoriu (2008)
10.1002/DC.20208
The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study
R. Saad (2005)
10.1074/jbc.M312372200
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion*
A. Rump (2004)
10.1111/j.1349-7006.2006.00246.x
Novel ELISA system for detection of N‐ERC/mesothelin in the sera of mesothelioma patients
K. Shiomi (2006)
10.1046/j.1469-7580.2002.00047_2.x
Aquaporin‐4 water channel expression in human vasogenic brain oedema
F. Geeson (2002)
10.1046/j.1365-2559.1997.5460776.x
Pathology of malignant mesothelioma
R. Attanoos (1997)
10.1007/s11060-005-9057-1
Increased expression of aquaporin 1 in human hemangioblastomas and its correlation with cyst formation
Yi-zhao Chen (2005)
10.1016/J.CTRV.2007.07.012
Assessment of tumor response in malignant pleural mesothelioma.
G. Ceresoli (2007)
10.1016/J.HOC.2005.09.007
Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
J. Creaney (2005)
10.1038/modpathol.3800732
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma
Y. Kato (2007)
10.1172/JCI118659
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.
L. S. King (1996)
10.1007/s00428-005-0005-4
Chromosomal alterations in early stages of malignant mesotheliomas
F. Simon (2005)
10.1164/rccm.200806-955ED
Screening for mesothelioma: more harm than good?
J. Van Meerbeeck (2008)
10.1309/AJCPWFW7O1FVFLKT
Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.
J. Shen (2009)
10.1038/sj.bjc.6690632
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
J. Schneider (1999)
10.1152/AJPLUNG.2000.278.5.L867
Aquaporin water channels and lung physiology.
A. Verkman (2000)
10.1002/(SICI)1097-0274(199609)30:3<241::AID-AJIM1>3.0.CO;2-1
Screening for asbestos-induced diseases in Finland.
K. Koskinen (1996)
10.1007/978-0-387-72114-9_12
Neoplasms of the Pleura
S. Hammar (2008)
10.1002/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F
The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis
P. Cury (1999)
10.1111/j.1440-1827.2007.02080.x
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
K. Kushitani (2007)
10.1002/DC.2840030209
The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions
J. Silverman (1987)
Aquaporin-4 is correlated with peri-tumoural oedema in meningiomas.
W. L. Tan (2004)
10.1111/j.1755-3768.2008.01259.x
Anti‐aquaporin‐4 antibody‐positive optic neuritis
M. Takagi (2009)
10.1158/1078-0432.CCR-05-1397
Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
M. Yen (2006)
10.1158/1078-0432.CCR-06-2161
Mesothelin Expression in Human Lung Cancer
M. Ho (2007)
A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
Y. Qiao (1997)
Screening and pathological diagnosis of asbestosis and mesothelioma: a review.
Z. Zalay (1992)
10.1007/s00424-007-0402-4
Clinical application of aquaporin research: aquaporin-1 in the peritoneal membrane
Tomoya Nishino (2007)
10.1016/j.jsb.2008.11.010
Acetazolamide reversibly inhibits water conduction by aquaporin-4.
Y. Tanimura (2009)
10.1016/J.HUMPATH.2005.09.002
Diagnostic significance of aquaporin-1 in liver tumors.
P. Mazal (2005)
10.1620/TJEM.210.307
Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.
T. Takahashi (2006)
10.1016/S0720-048X(01)00426-0
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
M. Metintas (2002)
10.1046/j.1365-2303.1997.42575425.x
p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology
F. Mayall (1997)
10.1006/MVRE.1999.2158
Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas.
M. Endo (1999)
10.1093/AJCP/94.6.698
Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis.
J. M. Esteban (1990)
10.1038/ncpneuro0764
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
S. Jarius (2008)
10.1152/ajplung.1998.275.1.L165
Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax.
S. Narasimhan (1998)
10.1001/archneur.65.5.629
Aquaporin-4 autoantibodies in a paraneoplastic context.
S. Pittock (2008)
10.1016/S0169-5002(01)00294-X
Computed tomography screening for lung cancer in asbestos-exposed workers.
M. Tiitola (2002)
10.1016/S0014-5793(03)01083-4
Aquaporin water channels: molecular mechanisms for human diseases1
P. Agre (2003)
10.1016/S0079-6123(08)00446-9
Potential utility of aquaporin modulators for therapy of brain disorders.
M. Papadopoulos (2008)
10.1001/ARCHNEUR.63.7.964
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
S. Pittock (2006)
10.5555/URI:PII:074025709290008W
The concept of mesothelioma in situ: implications for diagnosis and histogenesis.
D. Whitaker (1992)
10.1007/BF01069743
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
K. Segers (1994)
10.1002/PATH.1711680406
Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesothelium
M. Ramael (1992)
10.1074/jbc.M413627200
Aquaporin-4 Gene Disruption in Mice Reduces Brain Swelling and Mortality in Pneumococcal Meningitis*
M. Papadopoulos (2005)
10.1053/RMED.2001.1108
p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure.
R. Işık (2001)
10.1111/j.1572-0241.2006.00679.x
Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma
Jin Kim (2006)
10.1016/J.BMCL.2006.12.010
Identification of arylsulfonamides as Aquaporin 4 inhibitors.
V. Huber (2007)
10.1016/j.bmc.2007.12.040
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
V. Huber (2009)
10.1016/S0002-9629(15)40429-X
Role of aquaporin water channels in kidney and lung.
A. Verkman (1998)
10.1016/0046-8177(94)90115-5
p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens.
P. Cagle (1994)
10.1186/1471-2407-6-207
Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system
D. Vordermark (2006)
10.1016/S0031-3025(16)34974-1
Pathology of Lung Tumors
Harold D. Attwood (1998)
10.1053/HP.2000.6552
NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.
S. Lantuéjoul (2000)
10.1016/J.ANL.2006.11.012
Clinical significance of elevated osteopontin levels in head and neck cancer patients.
Mayumi Eto (2007)
10.1016/S0140-6736(97)08229-9
Mass screening for lung cancer with mobile spiral computed tomography scanner
S. Sone (1998)
10.1002/PATH.1711670103
Immunoreactivity for p‐170 glycoprotein in malignant mesothelioma and in non‐neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB‐1
M. Ramael (1992)
10.1016/j.jns.2009.08.040
Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis
A. Uzawa (2009)
10.1097/MCP.0b013e32832b98eb
Serum and pleural fluid biomarkers for mesothelioma
J. Creaney (2009)
10.1007/BF00735037
Distinction between cells in serous effusions using a panel of antibodies
A. F. Lauritzen (2004)
10.1038/sj.bjc.6600512
Increased aquaporin 1 water channel expression inhuman brain tumours
S. Saadoun (2002)
[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
T. Misu (2008)
10.1097/01.MP.0000056981.16578.C3
Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma
N. Ordóñez (2003)
Inhibition by mercuric chloride of aquaporin-1 in the parietal sheep peritoneum: an electrophysiologic study.
V. Liakopoulos (2006)
10.1016/j.bmc.2007.12.038
Inhibition of aquaporin 4 by antiepileptic drugs.
V. Huber (2009)
Ph
李幼升 (1989)
10.1111/j.1469-445X.2000.tb00028.x
Role of water channels in fluid transport studied by phenotype analysis of aquaporin knockout mice
A. Verkman (2000)
10.1046/j.1365-2559.2003.01686.x
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet‐derived growth factor‐receptor, P‐glycoprotein and Bcl‐2
R. Attanoos (2003)
10.1038/SJ.KI.5001847
Aquaporin-1 and sodium transport in the peritoneal membrane--need for more research?
V. Liakopoulos (2006)
10.1227/01.NEU.0000148904.57841.6B
Expression of the Aquaporin-1 Water Channel in Human Glial Tumors
K. Oshio (2005)
10.1016/S0272-6386(99)70317-3
Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport.
E. Goffin (1999)
10.1007/s00467-006-0411-0
Aquaporin-4 and brain edema
M. Papadopoulos (2007)
10.3109/01913128709048326
Serosal tissue: reactive tissue as a model for understanding mesotheliomas.
J. W. Bolen (1987)
10.1038/nrm1469
From structure to disease: the evolving tale of aquaporin biology
L. S. King (2004)
10.1002/(SICI)1097-0142(19990101)85:1<250::AID-CNCR41>3.0.CO;2-3
The use of epithelial membrane antigen and silver‐stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses
K. Metze (1999)
Screening for asbestbetingede sygdomme
C. Brauer (2009)
Small cell carcinomas of the lung express the Bcl-2 protein.
J. Ben-Ezra (1994)
10.1007/s00330-003-1851-6
CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature
M. Kebapçi (2003)
10.1016/S0169-5002(03)92469-X
Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma.
M. Hedman (2003)
10.4081/MONALDI.2009.374
Clinical utility of diagnostic markers for malignant pleural mesothelioma.
B. Grigoriu (2009)
p53 immunostaining in differential diagnosis of pleural mesothelial proliferations.
V. Esposito (1997)
10.1007/BF03256303
Biomarkers for Malignant Pleural Mesothelioma
L. Greillier (2012)
10.1016/j.neuroscience.2004.08.049
Anchoring of aquaporin-4 in brain: Molecular mechanisms and implications for the physiology and pathophysiology of water transport
M. Amiry-Moghaddam (2004)
10.1158/1078-0432.CCR-05-1477
Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer
R. Hassan (2006)
10.1073/PNAS.91.14.6255
The aquaporin family of molecular water channels.
M. Knepper (1994)
10.1093/AJCP/110.3.397
Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review.
D. Henderson (1998)
10.5271/SJWEH.706
Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign.
K. Koskinen (2003)
10.1373/CLINCHEM.2006.079327
MESOMARK: a potential test for malignant pleural mesothelioma.
H. L. Beyer (2007)
Tumors of the Serosal Membranes
A. Churg (2006)
10.1158/1078-0432.CCR-06-2144
Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment
B. Grigoriu (2007)
10.1186/1472-6793-2-4
Tetraethylammonium block of water flux in Aquaporin-1 channels expressed in kidney thin limbs of Henle's loop and a kidney-derived cell line.
A. Yool (2001)
10.1016/J.THORSURG.2004.06.007
Pathology of mesothelioma.
J. M. Corson (2004)
10.1016/j.lungcan.2008.02.012
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
K. Iwahori (2008)
[Anti-aquaporin 4-antibody detection system].
K. Tanaka (2008)
10.1146/ANNUREV.PH.58.030196.003155
Pathophysiology of the aquaporin water channels.
L. S. King (1996)
10.1159/000333991
p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.
S. S. Mullick (1996)
10.1097/00000478-198601000-00005
Reactive and Neoplastic Serosal Tissue: A Light-Microscopic, Ultrastructural, and Immunocytochemical Study
J. W. Bolen (1986)
10.1016/j.resp.2003.08.001
Role of aquaporin and sodium channel in pleural water movement
Jinjun Jiang (2003)
10.1023/A:1012292230480
The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.
Y. Soini (2001)
10.1016/j.neuroscience.2009.03.069
AQP4 gene deletion in mice does not alter blood–brain barrier integrity or brain morphology
S. Saadoun (2009)
10.1164/RCCM.200511-1789OC
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
A. Scherpereel (2006)
10.1213/ane.0b013e318187c313
Propofol Pretreatment Attenuates Aquaporin-4 Over-Expression and Alleviates Cerebral Edema After Transient Focal Brain Ischemia Reperfusion in Rats
Yue-ying Zheng (2008)
10.1152/AJPCELL.2000.279.6.C1744
Role of aquaporin water channels in pleural fluid dynamics.
Y. Song (2000)
10.1007/S11373-006-9143-1
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers.
L. Bao (2007)
10.1245/s10434-006-9192-8
Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
D. Baratti (2006)
10.1002/PATH.1711450204
Mesothelial healing: Morphological and kinetic investigations
D. Whitaker (1985)
10.1136/thx.2006.068114
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma
J. Creaney (2007)
10.1093/occmed/kqn018
Feasibility of a screening programme for lung cancer in former asbestos workers.
G. Mastrangelo (2008)
10.1164/rccm.200802-258OC
Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.
E. Park (2008)
10.1158/1078-0432.CCR-06-0472
Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma
M. Onda (2006)
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
P. Waters (2008)
10.1097/00000478-200009000-00001
The separation of benign and malignant mesothelial proliferations.
A. Churg (2000)
Effect of aquaporin-1 deletion on pleural fluid transport.
Jin-jun Jiang (2003)
The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
C. Szeto (2005)
10.1378/chest.08-2665
Malignant pleural mesothelioma: an update on biomarkers and treatment.
M. Ray (2009)
10.1016/J.BBAMEM.2006.02.025
Aquaporin-1 in the peritoneal membrane: Implications for water transport across capillaries and peritoneal dialysis.
O. Devuyst (2006)
10.1097/MCG.0b013e31802d6268
High Plasma Osteopontin Levels in Patients With Inflammatory Bowel Disease
Ryosuke Mishima (2007)
10.1620/TJEM.209.269
Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
T. Misu (2006)
10.1043/1543-2165(2008)132[23:CMVBHU]2.0.CO;2
Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Virganeyce Lyons-Boudreaux (2008)
10.1016/J.LUNGCAN.2004.10.003
Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
M. Falleni (2005)
[Expressions of aquaporin-1 on peritonea in hepatic cirrhotic rats with ascites].
Q. Liang (2005)
10.1016/j.neuroscience.2009.08.019
Aquaporin-4 in brain and spinal cord oedema
S. Saadoun (2010)
10.1038/modpathol.3800478
Immunocytochemical detection of XIAP in body cavity effusions and washes
M. Wu (2005)
10.1111/j.1365-2559.2007.02675.x
Osteopontin is linked to p65 and MMP‐9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma
A. Frey (2007)
10.1016/j.jneuroim.2009.04.001
Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica
T. Tani (2009)
10.1001/archneur.65.7.913
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
P. Waters (2008)
10.1046/j.1365-2559.2002.01352.x
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
R. Attanoos (2002)
10.1634/THEONCOLOGIST.12-10-1215
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
G. Fasola (2007)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1016/S0046-8177(98)90391-4
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.
M. Fleming (1998)
Acetazolamide inhibits aquaporin-1 protein expression and angiogenesis.
Y. Xiang (2004)
10.1097/00000478-200302000-00002
Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different Types: An Immunohistochemical Analysis of 596 Tumors in Comparison With Epithelioid Mesotheliomas of the Pleura
M. Miettinen (2003)
10.1358/DNP.2001.14.7.858424
Applications of aquaporin inhibitors.
A. Verkman (2001)
10.1007/s00330-006-0426-8
Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT
M. Das (2006)
10.1152/JAPPLPHYSIOL.01171.2001
Lung edema clearance: 20 years of progress: invited review: role of aquaporin water channels in fluid transport in lung and airways.
Z. Borok (2002)
10.3892/IJO.18.2.425
Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas.
T. Papp (2001)
10.1111/j.1365-2559.1993.tb00140.x
The frequency of p53 immunostaining in asbestos‐associated mesotheliomas and non‐asbestos‐associated mesotheliomas
F. Mayall (1993)
10.1016/S0140-6736(99)06093-6
Early Lung Cancer Action Project: overall design and findings from baseline screening
C. Henschke (1999)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1002/dc.2840030109
Epithelial membrane antigen in the cytodiagnosis of effusions and aspirates: Immunocytochemical and ultrastructural localization in benign and malignant cells
A. Walts (1987)
10.1111/j.1471-4159.2005.03362.x
Aquaporin‐4 gene deletion in mice increases focal edema associated with staphylococcal brain abscess
O. Bloch (2005)
10.1046/j.1469-7580.2002.00047_16.x
The aquaporin‐4 water channel and brain tumour oedema
S. Saadoun (2002)
Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study.
T. H. van der Kwast (1988)



This paper is referenced by
10.4172/2153-0602.S2-001
Exploration of Biomarkers for Asbestos Exposure and Occurrence of Malignant Mesothelioma Based on the Immunological Effects of Asbestos
Hidenori Matsuzaki (2013)
10.1007/s00018-014-1584-5
Role of microRNAs in malignant mesothelioma
A. Truini (2014)
1. Awadalla MS, Thapa SS, Burdon KP, Hewitt AW, Craig JE. The association of hepatocyte growth factor (HGF) gene with primary angle closure glaucoma in the Nepalese population. Mol Vis 2011;17:2248-54.
S. MacGregor (2011)
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
Seiki HasegawaNobuyuki (2012)
10.1136/jclinpath-2012-201303
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
D. Henderson (2013)
10.4103/1742-6413.99170
Parakeratotic-like cells in effusions — A clue to diagnosis of malignant mesothelioma
L. Gao (2012)
10.1007/s10147-011-0369-1
Pathological and molecular biological approaches to early mesothelioma
T. Tsujimura (2011)
Tohru TsujimuraIkuko ToriiAyuko SatoMisa Song
Kazuya Nakano (2012)
10.1183/09031936.00226111
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
I. Pantazopoulos (2012)
10.1007/s10147-011-0368-2
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
S. Hasegawa (2011)
10.1007/s00018-012-0950-4
Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension
M. Barrier (2012)
10.1093/carcin/bgz103
Biomarkers for malignant pleural mesothelioma: a meta-analysis.
Christina Gillezeau (2019)
10.3978/j.issn.2072-1439.2013.11.28
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
N. van Zandwijk (2013)
10.1136/jclinpath-2013-201609
Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA
D. Henderson (2013)
Semantic Scholar Logo Some data provided by SemanticScholar